Gossamer Bio News

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

Zacks Nov 14 08:40 ET

Gossamer Bio (GOSS) Gets a Buy From Oppenheimer

TipRanksNov 12 07:46 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target

BenzingaNov 11 10:10 ET

Gossamer Bio Analyst Ratings

BenzingaNov 11 10:08 ET · Ratings

Promising Progress and Expansion Potential of Gossamer Bio's Seralutinib Drive Buy Rating

TipRanksNov 11 06:17 ET · Ratings

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets

Yahoo FinanceNov 10 07:03 ET

Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations

TipRanksNov 8 23:24 ET

Gossamer Bio: Q3 Earnings Snapshot

Yahoo FinanceNov 7 16:59 ET

Earnings Flash (GOSS) GOSSAMER BIO Reports Q3 Revenue $9.5M

MT NewswiresNov 7 16:15 ET

Gossamer Bio | 10-Q: Q3 2024 Earnings Report

SECNov 7 16:04 ET · Announcements

Gossamer Bio | 8-K: Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

SECNov 7 16:04 ET

Gossamer Bio 3Q Loss/Shr 14c >GOSS

Dow JonesNov 7 16:03 ET

Express News | Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

ReutersNov 7 16:03 ET

Express News | Gossamer Bio Q3 Operating Expenses USD 43.399 Million

ReutersNov 7 16:03 ET

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireOct 7 17:01 ET

Express News | Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

ReutersOct 7 17:01 ET

Several Insiders Invested In Gossamer Bio Flagging Positive News

Yahoo FinanceOct 3 08:10 ET

12 Health Care Stocks Moving In Wednesday's After-Market Session

BenzingaOct 2 16:31 ET

Gossamer Bio Management to Meet With Oppenhiemer

TipRanksSep 27 09:10 ET

Bullish Outlook on Gossamer Bio's Seralutinib Efficacy and Market Potential

TipRanksSep 17 09:35 ET